These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20065134)

  • 1. Association of C-reactive protein with cognitive impairment.
    Noble JM; Manly JJ; Schupf N; Tang MX; Mayeux R; Luchsinger JA
    Arch Neurol; 2010 Jan; 67(1):87-92. PubMed ID: 20065134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
    Knopman DS; Roberts RO; Geda YE; Boeve BF; Pankratz VS; Cha RH; Tangalos EG; Ivnik RJ; Petersen RC
    Arch Neurol; 2009 May; 66(5):614-9. PubMed ID: 19433661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
    Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
    Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study.
    Dlugaj M; Gerwig M; Wege N; Siegrist J; Mann K; Bröcker-Preuss M; Dragano N; Moebus S; Jöckel KH; Bokhof B; Möhlenkamp S; Erbel R; Weimar C
    J Alzheimers Dis; 2012; 28(3):503-14. PubMed ID: 22008268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging.
    Quintino-Santos S; Diniz BS; Firmo JO; Moriguchi EH; Lima-Costa MF; Castro-Costa E
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):573-9. PubMed ID: 25132317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
    Klages J; Fisk JD
    Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype and memory in the sixth decade of life.
    Schultz MR; Lyons MJ; Franz CE; Grant MD; Boake C; Jacobson KC; Xian H; Schellenberg GD; Eisen SA; Kremen WS
    Neurology; 2008 May; 70(19 Pt 2):1771-7. PubMed ID: 18235080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.
    Debette S; Wolf PA; Beiser A; Au R; Himali JJ; Pikula A; Auerbach S; Decarli C; Seshadri S
    Neurology; 2009 Dec; 73(24):2071-8. PubMed ID: 20007524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.
    Cosentino S; Scarmeas N; Helzner E; Glymour MM; Brandt J; Albert M; Blacker D; Stern Y
    Neurology; 2008 May; 70(19 Pt 2):1842-9. PubMed ID: 18401023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.
    Solomon A; Turunen H; Ngandu T; Peltonen M; Levälahti E; Helisalmi S; Antikainen R; Bäckman L; Hänninen T; Jula A; Laatikainen T; Lehtisalo J; Lindström J; Paajanen T; Pajala S; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Soininen H; Kivipelto M
    JAMA Neurol; 2018 Apr; 75(4):462-470. PubMed ID: 29356827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.
    Gu Y; Razlighi QR; Zahodne LB; Janicki SC; Ichise M; Manly JJ; Devanand DP; Brickman AM; Schupf N; Mayeux R; Stern Y
    PLoS One; 2015; 10(7):e0123743. PubMed ID: 26221954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neighborhood psychosocial environment, apolipoprotein E genotype, and cognitive function in older adults.
    Lee BK; Glass TA; James BD; Bandeen-Roche K; Schwartz BS
    Arch Gen Psychiatry; 2011 Mar; 68(3):314-21. PubMed ID: 21383266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.